Developmental expression of morphoregulatory genes in the mouse embryo: An analytical approach using a novel technology

Biochemical and Molecular Medicine

Volumn 60, Issue 2, 1997, Pages 81-91

  Craig, J C ^a   Eberwine, J H ^c   Calvin, J A ^b   Wlodarczyk, B ^a   Bennett, G D ^a   Finnell, R H ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; GENE PRODUCT; PROTEIN P53;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; EMBRYO; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOUSE; NEURAL TUBE; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; REGULATOR GENE;

ANIMALIA; MURINAE;

EID: 0031127748     PISSN: 10773150     EISSN: None     Source Type: Journal    
DOI: 10.1006/bmme.1997.2576     Document Type: Article

References (42)

1. Langman J, Welch G W. Excess vitamin A and development of the cerebral cortex. J Comp Neurol. 131:1967;15-26.
2. Bannigan J, Cottell D. Ethanol teratogenicity in mice: An electron microscopic study. Teratology. 30:1984;281-290.
3. Schoenwolf G C, Smith J L. Mechanisms of neurulation: Traditional viewpoint and recent advances. Development. 109:1990;243-270.
4. Finnell R H, Wlodarczyk B C, Craig J C, Piedrahita J A, Bennett G D. Strain dependent alterations in the expression of folate pathway genes following teratogenic exposure to valproic acid in a mouse model. Am J Med Genet. 1997.
5. Snell G D, Fekete E, Hummel K P. The relation of mating ovulation and the estrus smear in the house mouse to the time of day. Anat Rec. 76:1948;30-54.
6. Cole W A, Trasler D G. Gene-teratogen interaction in insulin induced mouse exencephaly. Teratology. 22:1980;125-139.
7. Wlodarczyk B, Bennett G D, Calvin J H, Craig J C, Finnell R H. Arsenic-induced alterations in embryonic transcription factor gene expression: Implication for abnormal neural development. Dev Genet. 18:1996;306-315.
8. Stemple D L, Anderson D J. Isolation of a stem cell for neurons and glia from the mammalian neural crest. Cell. 71:1992;973-985.
9. Taylor L E, Bennett G D, Finnell R H. Altered gene expression in murine branchial arches followingin utero. J Craniofac Genet Dev Biol. 15:1995;13-25.
10. Eberwine J H, Yeh H, Miyashiro K, Cao Y, Nair S, Finnell R H, Zettel M, Coleman P. Analysis of gene expression in single live neurons. Proc Natl Acad Sci USA. 89:1992;3010-3014.
11. Elledge R M, Lee W H. Life and death by p53. Bioessays. 17:1995;923-930.
12. Davey S, Beach D. RACH2, a novel human gene that complements a fission yeast cell cycle checkpoint mutation. Mol Biol Cell. 6:1995;1411-1421.
13. Igarashi M, Nagata A, Jinno S, Suto K, Okayama H. Wee1+-like gene in human cells. Nature. 353:1991;80-83.
14. Miyashita T, Krajewski S, Krajewska M, Wang H G, Lin H K, Liebermann D A, Hoffman B, Reed J C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene. 9:1994;1799-1805.
15. Prehn J HM, Bindokas V P, Marcuccilli C J, Krajewski S, Reed J C, Miller R J. Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type b confers wide-ranging protection on rat hippocampal neurons. Proc Natl Acad Sci USA. 91:1994;12599-12603.
16. Sah V P, Attardi L D, Mulligan G J, Williams B O, Bronson R T, Jacks T. A subset of p53-deficient embryos exhibit exencephaly. Nature Genet. 10:1995;175-180.
17. Hockenberry D M. bcl-2, Bioessays. 17:1995;631-638.
18. Veis-Novack D, Korsmeyer S J. Bcl-2 protein expression during murine development. Am J Pathol. 145:1994;61-73.
19. Barnard J A, Lyons R M, Moses H L. The cell biology of transforming growth factor beta. Biochem Biophys Acta. 1032:1990;79.
20. Millan F A, Denhez F, Kondaiah P, Akhurst R J. Embryonic gene expression patterns of TGF b1, b2 and b3 suggest different developmental functionsin vivo. Development. 111:1991;131-143.
21. 1. Genes Dev. 9:1995;204-217.
22. Geng Y, Weinberg R A. Transforming growth factor beta effects on expression of G1 cylins and cyclin-dependent protein kinases. Proc Natl Acad Sci USA. 90:1993;10315-10319.
23. Fujiwara T, Mukhopadhyay T, Cai D W, Morris D K, Roth J A, Grimm E A. Retroviral-mediated transduction ofp53. Int J Cancer. 56:1995;834-839.
24. Blaydes J P, Schlumberger M, Wynford-Thomas D, Wyllie F S. Interaction between p53 and Tgfb-1 in control of epithelial cell proliferation. Oncogene. 10:1995;307-317.
25. Sokal R R, Rohlf J F. Biometry. 1981.
26. Searle S R. Linear Models. 1971;Wiley, New York.
27. Neter J, Wasserman W, Kutner M H. Applied Linear Regression Models. 1989;Irwin, Homewood/Boston.
28. SAS/STAT User's Guide Release 6.03. 1990;SAS Institute, Cary.
29. Rao C R. Linear Statistical Inference and Its Applications. 1973;Wiley, New York.
30. J, F, Rohlf, F, L, Bookstein, 1990, Traditional morphometrics, Proceedings of the Michigan Morphometrics Workshop, 77, 122, University of Michigan Museum of Zoology, Ann Arbor.
31. Johnson R A, Wichern D W. Principal components. Conmy S R. Applied Multivariate Statistical Analysis. 1992;356-395 Prentice Hall, Englewood Cliffs.
32. Mason R L, Gunst R F, Hess J L. Statistical Design & Analysis of Experiments. 1989;Wiley, New York.
33. Ryan J J, Prochownik E, Gottlieb E, Abel C A, Merino I J, Nunez G, Clarke M F. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci USA. 91:1994;5878-5882.
34. Wrana J L, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang X F, Massagne J. TGFb signals through a heteromeric protein kinase receptor complex. Cell. 71:1992;1003.
35. Chen R H, Ebner R, Derynck R. Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor. Science. 260:1993;1335-1338.
36. Clarke A R, Purdie C A, Harrison D J, Morris R G, Bird C C, Hooper M L, Wyllie A H. Thymocyte apoptosis induced byp53. Nature. 362:1993;849-852.
37. Mercer W E, Shields M T, Amin M, Sauve G J, Appella E, Romano J W, Ullrich S J. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA. 87:1990;6166-6170.
38. Diller L, Kassel J, Nelson C E, Gryka M A, Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker S J, Vogelstein B. p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol. 10:1990;572-578.
39. Reed J C. bcl-2 and the regulation of programmed cell death. J Cell Biol. 124:1994;1-6.
40. Vaux D L, Cory S, Adams J M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:1988;440-442.
41. Vaux D L, Weissman I L, Kim S K. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science. 258:1992;1955-1957.
42. Wang Y, Szekely L, Okan I, Klein G, Wiman G, Wiman K L. Wild type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell line. Oncogene. 8:1993;3427-3431.